Rosenbaum notes
A recent Reuters investigation reveals that Chinese active pharmaceutical ingredient (API) suppliers, including Hybio Pharmaceutical and Jiangsu Sinopep-Allsino Biopharmaceutical, are pivoting to generic drug production after U.S
Dan Skovronsky, Lillys Chief Scientific and Product Officer, described the results as extraordinary
2 Recent research has shown that glucagon-like peptide-1 (GLP-1), an intestinal hormone secreted in response to food consumption that provokes increased insulin secretion and reduced glucagon secretion from the pancreas, might play a role in alcohol-related behaviors
The primary therapeutic indication for GLP-1 agonists in the UK is type 2 diabetes management, with some formulations also licensed for weight management
Theres no evidence that they have any sort of substantially lingering effect once you stop taking them, said Patrick ONeil, Ph.D., director of the MUSC Weight Management Center and a professor in the Department of Psychiatry and Behavioral Sciences